How to Develop a National Formulary Based on the WHO Model Formulary - A Practical Guide
(2004; 45 pages) View the PDF document
Table of Contents
View the documentAbbreviations
Open this folder and view contents1 INTRODUCTION
Open this folder and view contents2 OVERVIEW OF THE NATIONAL FORMULARY PROCESS
Open this folder and view contents3 DEVELOPING THE PRELIMINARY INFORMATION SECTION
Open this folder and view contents4 DEVELOPMENT OF THERAPEUTIC INFORMATION AND MONOGRAPHS USING THE WHO MODEL FORMULARY
Close this folder5 ADDITIONAL SOURCES OF INFORMATION
View the documentThe evidence-based approach in formulary development
View the documentInformation retrieval
Open this folder and view contentsTypes of source
Open this folder and view contentsSearching for the best evidence
Open this folder and view contentsAccessibility
View the documentCritical appraisal
Open this folder and view contents6 DEVELOPING SPECIFIC INFORMATION SECTIONS
Open this folder and view contents7 PRODUCTION, DISTRIBUTION AND IMPLEMENTATION
Open this folder and view contents8 EVALUATION
Open this folder and view contents9 REVIEW AND UPDATE
View the documentREFERENCES
 

5 ADDITIONAL SOURCES OF INFORMATION

When the NF editorial team has completed its adaptation of the WMF material it may be necessary to include additional materials on medicines which are on the national EML, but not on the WHO list. Creating this new text requires a process of gathering and evaluating available information and then summarizing it for the NF in a way that is compatible with the adapted WMF material. Very thorough editing procedures will need to be followed to produce accurate, relevant and good quality information.

to previous section
to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: October 7, 2014